Literature DB >> 6687820

The use of Selectron afterloading equipment to simulate and extend the Manchester System for intracavitary therapy of the cervix uteri.

J M Wilkinson, C J Moore, H M Notley, R D Hunter.   

Abstract

When Selectron afterloading machines were introduced in the Christie Hospital the first aim was to reproduce, as closely as possible, the isodose distributions achieved with the traditional Manchester Radium System. This resulted in the establishment of standard pellet loading patterns, and standard treatment times, for programming the Selectron channels. However, the availability of whole-body CT scanning facilities provides a method of accurately locating the source positions with respect to the local anatomy and hence the possibility of dosage control based on doses to specific pelvic structures. Various computer programs have been written to extract source position data from the CT images, to allow the operator to propose pellet loading patterns and treatment times, and ultimately to display the resultant isodose distribution superposed on the cross-sectional scans. The effects on the dose distribution arising from changing the number of pellets, the pellet positions within the applicators, and the treatment times, are briefly discussed.

Mesh:

Substances:

Year:  1983        PMID: 6687820     DOI: 10.1259/0007-1285-56-666-409

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  2 in total

1.  Influence of brachytherapy applicators geometry on dose distribution in cervical cancer.

Authors:  E Senkus-Konefka; A Kobierska; J Jassem; K Serkies; A Badzio
Journal:  Strahlenther Onkol       Date:  1997-06       Impact factor: 4.033

2.  Developing a Treatment Planning Software Based on TG-43U1 Formalism for Cs-137 LDR Brachytherapy.

Authors:  Sedigheh Sina; Reza Faghihi; Ali Soleimani Meigooni; Zahra Siavashpour; Mohammad Amin Mosleh-Shirazi
Journal:  Iran Red Crescent Med J       Date:  2013-08-05       Impact factor: 0.611

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.